380 related articles for article (PubMed ID: 25333770)
1. Early interaction of adeno-associated virus serotype 8 vector with the host immune system following intramuscular delivery results in weak but detectable lymphocyte and dendritic cell transduction.
Gernoux G; Guilbaud M; Dubreil L; Larcher T; Babarit C; Ledevin M; Jaulin N; Planel P; Moullier P; Adjali O
Hum Gene Ther; 2015 Jan; 26(1):1-13. PubMed ID: 25333770
[TBL] [Abstract][Full Text] [Related]
2. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
3. Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors.
Lu Y; Song S
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17158-62. PubMed ID: 19805176
[TBL] [Abstract][Full Text] [Related]
4. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo.
Nakai H; Yant SR; Storm TA; Fuess S; Meuse L; Kay MA
J Virol; 2001 Aug; 75(15):6969-76. PubMed ID: 11435577
[TBL] [Abstract][Full Text] [Related]
5. Genomic stability of self-complementary adeno-associated virus 2 during early stages of transduction in mouse muscle in vivo.
Ren C; Kumar S; Shaw DR; Ponnazhagan S
Hum Gene Ther; 2005 Sep; 16(9):1047-57. PubMed ID: 16149903
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models.
Davidoff AM; Gray JT; Ng CY; Zhang Y; Zhou J; Spence Y; Bakar Y; Nathwani AC
Mol Ther; 2005 Jun; 11(6):875-88. PubMed ID: 15922958
[TBL] [Abstract][Full Text] [Related]
7. Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice.
Nakai H; Fuess S; Storm TA; Muramatsu S; Nara Y; Kay MA
J Virol; 2005 Jan; 79(1):214-24. PubMed ID: 15596817
[TBL] [Abstract][Full Text] [Related]
8. Modified infusion procedures affect recombinant adeno-associated virus vector type 2 transduction in the liver.
Ohashi K; Nakai H; Couto LB; Kay MA
Hum Gene Ther; 2005 Mar; 16(3):299-306. PubMed ID: 15812225
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors.
Sarukhan A; Soudais C; Danos O; Jooss K
J Gene Med; 2001; 3(3):260-70. PubMed ID: 11437331
[TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens.
Nicolson SC; Li C; Hirsch ML; Setola V; Samulski RJ
J Virol; 2016 Aug; 90(16):7019-7031. PubMed ID: 27147738
[TBL] [Abstract][Full Text] [Related]
11. Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 Vectors.
Ferrand M; Da Rocha S; Corre G; Galy A; Boisgerault F
Mol Ther; 2015 Jun; 23(6):1022-1033. PubMed ID: 25881000
[TBL] [Abstract][Full Text] [Related]
12. Five Years of Successful Inducible Transgene Expression Following Locoregional Adeno-Associated Virus Delivery in Nonhuman Primates with No Detectable Immunity.
Guilbaud M; Devaux M; Couzinié C; Le Duff J; Toromanoff A; Vandamme C; Jaulin N; Gernoux G; Larcher T; Moullier P; Le Guiner C; Adjali O
Hum Gene Ther; 2019 Jul; 30(7):802-813. PubMed ID: 30808235
[TBL] [Abstract][Full Text] [Related]
13. Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.
Jooss K; Chirmule N
Gene Ther; 2003 Jun; 10(11):955-63. PubMed ID: 12756416
[TBL] [Abstract][Full Text] [Related]
14. Recombinant adeno-associated virus vector: Is it ideal for gene delivery in liver transplantation?
Yang ZF; Wu XB; Tsui TY; Hou YD; Luk JM; Fan ST
Liver Transpl; 2003 Apr; 9(4):411-20. PubMed ID: 12682895
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo.
Nakai H; Storm TA; Kay MA
J Virol; 2000 Oct; 74(20):9451-63. PubMed ID: 11000214
[TBL] [Abstract][Full Text] [Related]
16. Major subsets of human dendritic cells are efficiently transduced by self-complementary adeno-associated virus vectors 1 and 2.
Veron P; Allo V; Rivière C; Bernard J; Douar AM; Masurier C
J Virol; 2007 May; 81(10):5385-94. PubMed ID: 17314166
[TBL] [Abstract][Full Text] [Related]
17. Pristimerin enhances recombinant adeno-associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivo.
Wang LN; Wang Y; Lu Y; Yin ZF; Zhang YH; Aslanidi GV; Srivastava A; Ling CQ; Ling C
J Integr Med; 2014 Jan; 12(1):20-34. PubMed ID: 24461592
[TBL] [Abstract][Full Text] [Related]
18. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.
Sarukhan A; Camugli S; Gjata B; von Boehmer H; Danos O; Jooss K
J Virol; 2001 Jan; 75(1):269-77. PubMed ID: 11119597
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5.
Zhong L; Li W; Li Y; Zhao W; Wu J; Li B; Maina N; Bischof D; Qing K; Weigel-Kelley KA; Zolotukhin I; Warrington KH; Li X; Slayton WB; Yoder MC; Srivastava A
Hum Gene Ther; 2006 Mar; 17(3):321-33. PubMed ID: 16544981
[TBL] [Abstract][Full Text] [Related]
20. Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: implications for gene doping.
Ni W; Le Guiner C; Gernoux G; Penaud-Budloo M; Moullier P; Snyder RO
Gene Ther; 2011 Jul; 18(7):709-18. PubMed ID: 21390073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
